Doctor profile · Federal record
Dr. Daniel Erhardt, M.D.
Rheumatology Physician (CMS: Rheumatology) · Longmont, CO
- NPI 1467870212
- Accepts Medicare
- MIPS 95.3 / 100 · 2023
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1715 Iron Horse Dr Ste 150
Longmont, CO 805019756
(720) 494-4700 - Mailing address
-
Po Box 35380
Las Vegas, NV 891335380
Credentials & registration
- NPI registered
- March 2014 — 12 yrs on file
- Profile last updated
- March 28, 2025
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Colorado #DR.0059030
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467870212. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
21,091
Distinct HCPCS
10
Medicare allowed
$691,551
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 5,696 | 18 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,625 | 27 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,400 | 59 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 1,920 | 19 | $23 | |
J9312 |
Injection, rituximab, 10 mg | 1,700 | 12 | $80 | |
J1201 |
Injection, cetirizine hydrochloride, 0.5 mg | 800 | 28 | $15 | |
Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 720 | 11 | $27 | |
J7050 |
Infusion, normal saline solution, 250 cc | 244 | 116 | $1 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 202 | 85 | $29 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 177 | 104 | $53 |
In context: peer comparison
Among 4 peers in Longmont Rheumatology Physician, average services per provider: 1,282. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$877
Transactions
38
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 13 | $285.86 | |
| AstraZeneca Pharmaceuticals Lp | 8 | $197.35 | |
| Abbvie INC. | 5 | $137.08 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $55.58 | |
| Sobi, INC | 2 | $45.19 | |
| Pfizer INC. | 2 | $42.48 | |
| GlaxoSmithKline, LLC. | 2 | $41.84 | |
| Genentech USA, INC. | 1 | $20.76 | |
| Aurinia Pharma U.S., INC. | 1 | $20.51 | |
| Ucb, INC. | 1 | $16.78 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $14.06 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,012
Patients
340
Total drug cost
$42,788
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 258 | 97 | $2,934 |
| Methotrexate (Methotrexate Sodium) | Brand | 159 | 58 | $8,587 |
| Hydroxychloroquine Sulfate | Generic | 117 | 45 | $10,544 |
| Folic Acid | Generic | 68 | 29 | $430 |
| Celecoxib | Generic | 65 | 30 | $2,137 |
| Pregabalin | Generic | 55 | 20 | $2,366 |
| Gabapentin | Generic | 42 | 17 | $1,269 |
| Allopurinol | Generic | 38 | 16 | $923 |
| Meloxicam | Generic | 38 | 14 | $119 |
| Duloxetine Hcl | Generic | 32 | 0 | $466 |
Frequently asked questions
What is Dr. Daniel Erhardt's medical specialty?
Dr. Daniel Erhardt practices Rheumatology Physician in Longmont, CO.
Where does Dr. Daniel Erhardt practice?
Dr. Daniel Erhardt practices at 1715 Iron Horse Dr Ste 150, Longmont, CO 805019756. Office phone: 7204944700.
What is Dr. Daniel Erhardt's NPI?
Dr. Daniel Erhardt's National Provider Identifier (NPI) is 1467870212, issued by NPPES.
Does Dr. Daniel Erhardt accept Medicare assignment?
Yes. Dr. Daniel Erhardt accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Erhardt commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.